hylan G-F 20 Synvisc-One
Selected indexed studies
- A Comprehensive Review of Viscosupplementation in Osteoarthritis of the Knee. (Orthop Rev (Pavia), 2021) [PMID:34745480]
- Development of Systemic Inflammatory Polyarthritis After Zygapophyseal Joint Injection With Hylan G-F 20 (Synvisc-One). (Am J Phys Med Rehabil, 2018) [PMID:28708631]
- Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis. (Clinicoecon Outcomes Res, 2019) [PMID:31413608]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A Comprehensive Review of Viscosupplementation in Osteoarthritis of the Knee. (2021) pubmed
- Development of Systemic Inflammatory Polyarthritis After Zygapophyseal Joint Injection With Hylan G-F 20 (Synvisc-One). (2018) pubmed
- Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis. (2019) pubmed
- Immunological response to bolus versus multiple injections of hylan G-F 20 (Synvisc) in a murine biocompatibility model. (2014) pubmed
- Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline. (2019) pubmed
- Methylobacterium infection of an arthritic knee. (2019) pubmed
- Twelve-month efficacy of carboxymethyl-chitosan in refractory knee osteoarthritis: A randomized controlled trial (PIONEER). (2025) pubmed
- Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety. (2017) pubmed
- A Comparison Between Rheological Properties of Intra-articular Hyaluronic Acid Preparations and Reported Human Synovial Fluid. (2018) pubmed
- Improvement in condition-specific and generic quality of life outcomes in patients with knee osteoarthritis following single-injection Synvisc: results from the LOBRAS study. (2017) pubmed